Carasent

Q4 2024 highlights

• Net sales amounted to MSEK 78.7 (64.4), representing a net sales growth of 22%.
• Organic growth was 15% while net acquisitions and divestments in the last twelve months accounted for MSEK 5.5 or 9% of the growth.
• Recurring revenues amounted to MSEK 70.0 (58.5), with organic recurring revenue growth of 15%.
• EBITDA amounted to MSEK -8.7 (6.1), representing an EBITDA margin of -11% (9%).
• Adjusted EBITDA margin was 15% (10%).
• Adjusted EBITDAC margin was 5% (-13%).
• Operating result, EBIT, amounted to MSEK -24.1 (-5.9).
• Cash flow from operating activities amounted to MSEK 16.3 (4.6).
• Net income amounted to MSEK -24.2 (10.8).
• Earnings per share, before and after dilution, amounted to SEK -0.34 (0.14).

The period 2024 highlights

• Net sales amounted to MSEK 275.3 (245.2), representing a net sales growth of 12%.
• Organic growth was 14% while net acquisitions and divestments in the last twelve months accounted for SEK -1.4 million or -1% of the growth.
• Recurring revenues amounted to MSEK 252.0 (223.0) , with organic recurring revenue growth of 16%.
• EBITDA amounted to MSEK 11.6 (13.4), representing an EBITDA margin of 4% (5%).
• Adjusted EBITDA margin was 15% (9%).
• Adjusted EBITDAC margin was 0% (-18%).
• Operating result, EBIT, amounted to MSEK -54.5 (-77.9).
• Cash flow from operating activities amounted to MSEK 37.7 (-4.0).
• Net income amounted to MSEK -42.3 (-46.7).
• Earnings per share, before and after dilution, amounted to SEK -0.58 (-0.60).

The results will be presented as a webcast at 8:00 CET today. If you wish to participate via webcast please use the link below.
Carasent Q4 Report 2024

For further details please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493